Učitavanje...
Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C
Telaprevir (TVR) is used for the treatment of chronic hepatitis C in a combination therapy with pegylated-interferon and ribavirin. Although renal dysfunction is one of the critical adverse outcomes of this treatment, little is known regarding the mechanism of its onset. The present study assessed t...
Spremljeno u:
| Izdano u: | Exp Ther Med |
|---|---|
| Glavni autori: | , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840744/ https://ncbi.nlm.nih.gov/pubmed/27168803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3133 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|